000 03684nlm1a2200433 4500
001 663489
005 20231030041856.0
035 _a(RuTPU)RU\TPU\network\34659
035 _aRU\TPU\network\34591
090 _a663489
100 _a20210216a2020 k y0engy50 ba
101 0 _aeng
135 _adrcn ---uucaa
181 0 _ai
182 0 _ab
200 1 _aNeuroprotective Effects of a Novel Inhibitor of c-Jun N-Terminal Kinase in the Rat Model of Transient Focal Cerebral Ischemia
_fM. B. Plotnikov, G. A. Chernysheva, V. A. Smolyakova [et al.]
203 _aText
_celectronic
300 _aTitle screen
320 _a[References: 52 tit.]
330 _aA novel specific inhibitor of c-Jun N-terminal kinase, 11H-indeno[1,2-b]quinoxalin-11-one oxime sodium salt (IQ-1S), has a high affinity to JNK3 compared to JNK1/JNK2. The aim of this work was to study the mechanisms of neuroprotective activity of IQ-1S in the models of reversible focal cerebral ischemia (FCI) in Wistar rats. The animals were administered with an intraperitoneal injection of IQ-1S (5 and 25 mg/kg) or citicoline (500 mg/kg). Administration of IQ-1S exerted a pronounced dose-dependent neuroprotective effect, not inferior to the effects of citicoline. Administration of IQ-1S at doses of 5 and 25 mg/kg reduced the infarct size by 20% and 50%, respectively, 48 h after FCI, whereas administration of citicoline reduced the infarct size by 34%. The administration of IQ-1S was associated with a faster amelioration of neurological status. Control rats showed a 2.0-fold increase in phospho-c-Jun levels in the hippocampus compared to the corresponding values in sham-operated rats 4 h after FCI. Administration of IQ-1S at a dose of 25 mg/kg reduced JNK-dependent phosphorylation of c-Jun by 20%. Our findings suggest that IQ-1S inhibits JNK enzymatic activity in the hippocampus and protects against stroke injury when administered in the therapeutic and prophylactic regimen in the rat model of FCI.
461 _tCells
463 _tVol. 9, iss. 8
_v[1860, 12 p.]
_d2020
610 1 _aэлектронный ресурс
610 1 _aтруды учёных ТПУ
701 1 _aPlotnikov
_bM. B.
_gMark Borisovich
701 1 _aChernysheva
_bG. A.
_gGalina Anatoljevna
701 1 _aSmolyakova
_bV. A.
_gVeronika Alekseevna
701 1 _aAliev
_bO. I.
_gOleg Ibragimovich
701 1 _aTrofimova
_bE. S.
_gEvgeniya Sergeevna
701 1 _aSherstoboev
_bE. Yu.
_gEgeny Yurjevich
701 1 _aOsipenko
_bA. N.
_gAnton Nikolaevich
701 1 _aKhlebnikov
_bA. I.
_cChemist
_cProfessor of Tomsk Polytechnic University
_f1963-
_gAndrey Ivanovich
_2stltpush
_3(RuTPU)RU\TPU\pers\33927
701 1 _aAnfinogenova
_bYa. J.
_cLinguist
_cLecturer of Tomsk Polytechnic University, Doctor of medical sciences
_f1970-
_gYana Jonovna
_2stltpush
_3(RuTPU)RU\TPU\pers\33592
701 1 _aSchepetkin (Shchepyotkin)
_bI. A.
_cdoctor-biophysicist
_cleading researcher of Tomsk Polytechnic University, candidate of medical science
_f1962-
_gIgor Aleksandrovich
_2stltpush
_3(RuTPU)RU\TPU\pers\37358
701 1 _aAtochin
_bD. N.
_cneuroscientist
_cThe Head of the Laboratory of Tomsk Polytechnic University
_f1960-
_gDmitry Nikolaevich
_2stltpush
_3(RuTPU)RU\TPU\pers\37514
712 0 2 _aНациональный исследовательский Томский политехнический университет
_bИнженерная школа новых производственных технологий
_bНаучно-образовательный центр Н. М. Кижнера
_h7872
_2stltpush
_3(RuTPU)RU\TPU\col\23556
801 2 _aRU
_b63413507
_c20210216
_gRCR
856 4 _uhttps://doi.org/10.3390/cells9081860
942 _cCF